Speaker illustration

Associate Professor Maciej Wybraniec

School of Medicine in Katowice, Medical University of Silesia, Katowice (Poland)

Member of:

European Society of Cardiology
EAPCI

Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation and atrial flutter: insights from the LATTEE registry

Event: ESC Congress 2022

Topic: Oral Anticoagulation

Session: Stroke prevention in atrial fibrillation

Thumbnail

Pharmacological cardioversion of recent-onset atrial fibrillation in patients with chronic kidney disease: sub-analysis of the CANT Study

Event: ESC Congress 2021 - The Digital Experience

Topic: Rhythm Control, Cardioversion

Session: Atrial fibrillation e-posters

Thumbnail

CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis

Event: ESC Congress 2021 - The Digital Experience

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Session: Cardiovascular Disease in Special Populations ePosters

Thumbnail

Antazoline for pharmacological cardioversion of atrial fibrillation: the results of the high-volume multicenter CANT study

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Rhythm Control, Cardioversion

Session: Atrial Fibrillation ePosters

Thumbnail

Managed Care after Acute Myocardial Infarction (MC-AMI) reduces MACE by 45% in 3-month follow-up - results form Poland's National Health Fund program of post-MI care. A single center analysis

Event: ESC CONGRESS 2019

Topic: Secondary Prevention

Session: Risk factors and prevention

Thumbnail

Efficacy of comprehensive Managed Care after Acute Myocardial Infarction (MC-AMI) in a long-term follow-up - preliminary experience of a single high-volume center.

Event: ESC CONGRESS 2019

Topic: Secondary Prevention

Session: Risk factors and prevention

Thumbnail

Propensity score matched analysis of antazoline mesylate vs. amiodarone or propafenone for pharmacological cardioversion of short-duration atrial fibrillation

Event: ESC CONGRESS 2019

Topic: Rhythm Control, Cardioversion

Session: Drug treatment for atrial fibrillation

Thumbnail

Renal resistive index is associated with adverse cardiovascular events at 24 months in patients with coronary artery disease submitted to coronary angiography

Event: ESC Congress 2018

Topic: Noninvasive Diagnostic Methods

Session: Coronary artery disease : diagnosis pharmacotherapy and revascularisation

Thumbnail

Plasma renalase concentration in patients with atrial fibrillation undergoing pulmonary vein isolation

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation ablation

Thumbnail

Post-procedural increase of urinary kidney injury molecule type 1 predicts outcome in patients with coronary artery disease submitted to coronary angiography

Event: ESC CONGRESS 2017

Topic: PCI: long-term outcome

Session: Long-Term outcomes of PCI

Thumbnail

ESC 365 is supported by

logo Novo Nordisk